Trials / Unknown
UnknownNCT02718950
Influence of Liraglutide, a GLP-1 Receptor Agonist, on Brown Adipose Tissue (BAT) Activity in Humans
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- University of Campinas, Brazil · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to access liraglutide influence brown adipose tissue recruitment and its thermogenic effect through hypothalamic activation in obese individuals.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Liraglutide 3.0 mg | Subjects will use liraglutide 3.0 mg for 2 weeks |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2017-03-01
- Completion
- 2017-04-01
- First posted
- 2016-03-24
- Last updated
- 2016-03-24
Source: ClinicalTrials.gov record NCT02718950. Inclusion in this directory is not an endorsement.